Expression of truncated22–24 or full-length25 utrophin significantly ameliorates the phenotype of mdx mice and provides the rationale for harnessing pharmacological upregulation of endogenous utrophin as a therapeutic strategy for DMD. Here, UTRN is linked to Duchenne muscular dystrophy.